Showing results (151-160 of 236) with videos related to

Sort By:
Pageof 24
Antimicrobial Agents and Chemotherapy|November 1, 2017
Identification of Vancomycin Exposure-Toxicity Thresholds in Hospitalized Patients Receiving Intravenous VancomycinEvan J Zasowski, Kyle P Murray, Trang D Trinh, et al.
Open Forum Infectious Diseases|July 16, 2020
Old In Vitro Antimicrobial Breakpoints Are Misleading Stewardship Efforts, Delaying Adoption of Innovative Therapies, and Harming PatientsPaul G Ambrose, Sujata M Bhavnani, David R Andes, et al.
Open Forum Infectious Diseases|June 6, 2020
The Impact of Multidrug-Resistant Organisms on Outcomes in Patients With Diabetic Foot InfectionsOryan Henig, Jason M Pogue, Emily Martin, et al.
Infectious Diseases and Therapy|October 23, 2019
Relationship Status between Vancomycin Loading Dose and Treatment Failure in Patients with MRSA Bacteremia: It's ComplicatedJessica K Ortwine, Evan J Zasowski, Jason M Pogue, et al.
Pharmacotherapy|September 20, 2011
Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycin consensus guidelinesRavina Kullar, Steven N Leonard, Susan L Davis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2025
First report of treatment-emergent resistance to cefepime-zidebactam in Pseudomonas aeruginosaAva J Dorazio, Samuel L Aitken, Virginia M Pierce, et al.
International Journal of Antimicrobial Agents|January 2, 2017
Polymyxin B in combination with meropenem against carbapenemase-producing Klebsiella pneumoniae: pharmacodynamics and morphological changesRajnikant Sharma, Saloni Patel, Cely Abboud, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 6, 2026
The Impact of Colistin MIC on Clinical Failure and Mortality: Insights from the OVERCOME TrialJason M Pogue, Michael J Rybak, Jacinda C Abdul-Mutakabbir, et al.
Antimicrobial Agents and Chemotherapy|October 17, 2012
Epidemiology of vancomycin-resistant Enterococcus faecalis: a case-case-control studyKayoko Hayakawa, Dror Marchaim, Mohan Palla, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2025
The Impact of Synergistic Therapy Between Colistin and Meropenem on Outcomes of Patients With Pneumonia or Bloodstream Infection Due to Carbapenem-Resistant Gram-Negative PathogensMariya Huralska, Jason M Pogue, Michael Rybak, et al.
Pageof 24